These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Inflammation-based scores do not predict post-transplant recurrence of hepatocellular carcinoma in patients within Milan criteria. Parisi I; Tsochatzis E; Wijewantha H; Rodríguez-Perálvarez M; De Luca L; Manousou P; Fatourou E; Pieri G; Papastergiou V; Davies N; Yu D; Luong T; Dhillon AP; Thorburn D; Patch D; O'Beirne J; Meyer T; Burroughs AK Liver Transpl; 2014 Nov; 20(11):1327-35. PubMed ID: 25088400 [TBL] [Abstract][Full Text] [Related]
6. Liver transplantation in patients with hepatocellular carcinoma across Milan criteria. Herrero JI; Sangro B; Pardo F; Quiroga J; Iñarrairaegui M; Rotellar F; Montiel C; Alegre F; Prieto J Liver Transpl; 2008 Mar; 14(3):272-8. PubMed ID: 18306328 [TBL] [Abstract][Full Text] [Related]
7. Benefit of downsizing hepatocellular carcinoma in a liver transplant population. Jang JW; You CR; Kim CW; Bae SH; Yoon SK; Yoo YK; Kim DG; Choi JY Aliment Pharmacol Ther; 2010 Feb; 31(3):415-23. PubMed ID: 19821808 [TBL] [Abstract][Full Text] [Related]
8. Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolization. Kim DY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC; Shin SW; Choo SW; Do YS; Rhee JC World J Gastroenterol; 2006 Nov; 12(43):6992-7. PubMed ID: 17109521 [TBL] [Abstract][Full Text] [Related]
9. Survival benefit of transplantation for recurrence of hepatocellular carcinoma after liver resection. Tuci F; Vitale A; D'Amico F; Gringeri E; Neri D; Zanus G; Bassi D; Polacco M; Boetto R; Lodo E; Germani G; Burra P; Angeli P; Cillo U Transplant Proc; 2014 Sep; 46(7):2287-9. PubMed ID: 25242770 [TBL] [Abstract][Full Text] [Related]
10. 11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon's perspective. Cheung TT; Ho CL; Lo CM; Chen S; Chan SC; Chok KS; Fung JY; Yan Chan AC; Sharr W; Yau T; Poon RT; Fan ST J Nucl Med; 2013 Feb; 54(2):192-200. PubMed ID: 23321459 [TBL] [Abstract][Full Text] [Related]
11. Liver Transplantation for Advanced Hepatocellular Carcinoma after Downstaging Without Up-Front Stage Restrictions. Chapman WC; Garcia-Aroz S; Vachharajani N; Fowler K; Saad N; Lin Y; Wellen J; Tan B; Khan AS; Doyle MB J Am Coll Surg; 2017 Apr; 224(4):610-621. PubMed ID: 28069527 [TBL] [Abstract][Full Text] [Related]
12. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis. Kulik L; Heimbach JK; Zaiem F; Almasri J; Prokop LJ; Wang Z; Murad MH; Mohammed K Hepatology; 2018 Jan; 67(1):381-400. PubMed ID: 28859222 [TBL] [Abstract][Full Text] [Related]
13. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC. Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297 [TBL] [Abstract][Full Text] [Related]
14. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. Lee KK; Kim DG; Moon IS; Lee MD; Park JH J Surg Oncol; 2010 Jan; 101(1):47-53. PubMed ID: 19798686 [TBL] [Abstract][Full Text] [Related]
15. [Influence of treatment of hepatocellular carcinoma before liver transplantation on post transplant tumor recurrence and survival]. Díaz-Sánchez A; Matilla A; Núñez O; Merino B; Peligros I; Rincón D; Salcedo M; Lo Iacono O; Vega Catalina M; Clemente G; Bañares R Gastroenterol Hepatol; 2010 Mar; 33(3):155-64. PubMed ID: 19945770 [TBL] [Abstract][Full Text] [Related]
16. How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE? Otto G; Schuchmann M; Hoppe-Lotichius M; Heise M; Weinmann A; Hansen T; Pitton MP J Hepatol; 2013 Aug; 59(2):279-84. PubMed ID: 23587474 [TBL] [Abstract][Full Text] [Related]
17. Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma. Millonig G; Graziadei IW; Freund MC; Jaschke W; Stadlmann S; Ladurner R; Margreiter R; Vogel W Liver Transpl; 2007 Feb; 13(2):272-9. PubMed ID: 17256758 [TBL] [Abstract][Full Text] [Related]
18. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm. Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890 [TBL] [Abstract][Full Text] [Related]
19. Liver Transplantation is a Preferable Alternative to Palliative Therapy for Selected Patients with Advanced Hepatocellular Carcinoma. Aravinthan AD; Bruni SG; Doyle AC; Thein HH; Goldaracena N; Issachar A; Lilly LB; Selzner N; Bhat M; Sreeharsha B; Selzner M; Ghanekar A; Cattral MS; McGilvray ID; Greig PD; Renner EL; Grant DR; Sapisochin G Ann Surg Oncol; 2017 Jul; 24(7):1843-1851. PubMed ID: 28160137 [TBL] [Abstract][Full Text] [Related]
20. Liver Transplantation in Patients With Hepatocellular Carcinoma Outside the Milan Criteria After Downstaging: Is It Worth It? Cascales-Campos P; Martinez-Insfran LA; Ramirez P; Ferreras D; Gonzalez-Sanchez MR; Sanchez-Bueno F; Robles R; Pons JA; Capel A; Parrilla P Transplant Proc; 2018 Mar; 50(2):591-594. PubMed ID: 29579861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]